{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:44:20Z","timestamp":1792712660492,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the emergence of antimicrobial resistances. Therefore, a personalized therapy is of great interest for improved patients\u2019 outcome and will reduce in long-term the prevalence of multidrug-resistances. In this context, on-site monitoring of the antibiotic blood concentration is fundamental to facilitate an individual adjustment of the antibiotherapy. Herein, we present a bioinspired approach for the bedside monitoring of free accessible \u00df-lactam antibiotics, including penicillins (piperacillin) and cephalosporins (cefuroxime and cefazolin) in untreated plasma samples. The introduced system combines a disposable microfluidic chip with a naturally occurring penicillin-binding protein, resulting in a high-performance platform, capable of gauging very low antibiotic concentrations (less than 6 ng ml<jats:sup>\u22121<\/jats:sup>) from only 1\u2009\u00b5l of serum. The system\u2019s applicability to a personalized antibiotherapy was successfully demonstrated by monitoring the pharmacokinetics of patients, treated with \u00df-lactam antibiotics, undergoing surgery.<\/jats:p>","DOI":"10.1038\/s41598-017-03338-z","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T08:34:23Z","timestamp":1496651663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical on-site monitoring of \u00df-lactam antibiotics for a personalized antibiotherapy"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-330X","authenticated-orcid":false,"given":"R.","family":"Bruch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chatelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-7489","authenticated-orcid":false,"given":"S.","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-1198","authenticated-orcid":false,"given":"C.","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"3338_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jemermed.2014.06.037","volume":"47","author":"SK Flaherty","year":"2014","unstructured":"Flaherty, S. K. et al. Septic shock and adequacy of early empiric antibiotics in the emergency department. J. Emerg. Med. \n                           47, 601\u2013607 (2014).","journal-title":"J. Emerg. Med."},{"key":"3338_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger, R. P. et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. \n                           39, 165\u2013228 (2013).","journal-title":"Intensive Care Med."},{"key":"3338_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijantimicag.2015.10.019","volume":"47","author":"J-J Hao","year":"2016","unstructured":"Hao, J.-J., Chen, H. & Zhou, J.-X. Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis. Int. J. Antimicrob. Agents \n                           47, 28\u201335 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"3338_CR4","first-page":"w14368","volume":"146","author":"M Osthoff","year":"2016","unstructured":"Osthoff, M., Siegemund, M., Balestra, G., Abdul-Aziz, M. H. & Roberts, J. A. Prolonged administration of \u03b2-lactam antibiotics - a comprehensive review and critical appraisal. Swiss Med. Wkly. \n                           146, w14368 (2016).","journal-title":"Swiss Med. Wkly."},{"key":"3338_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","volume":"44","author":"F Pea","year":"2005","unstructured":"Pea, F., Viale, P. & Furlanut, M. Antimicrobial Therapy in Critically Ill Patients. Clin. Pharmacokinet. \n                           44, 1009\u20131034 (2005).","journal-title":"Clin. Pharmacokinet."},{"key":"3338_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1378\/chest.115.2.462","volume":"115","author":"MH Kollef","year":"1999","unstructured":"Kollef, M. H., Sherman, G., Ward, S. & Fraser, V. J. Inadequate Antimicrobial Treatment of Infections: A Risk Factor for Hospital Mortality Among Critically Ill Patients. Chest \n                           115, 462\u2013474 (1999).","journal-title":"Chest"},{"key":"3338_CR7","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1097\/CCM.0b013e318180fe62","volume":"36","author":"Ja Roberts","year":"2008","unstructured":"Roberts, J. a., Kruger, P., Paterson, D. L. & Lipman, J. Antibiotic resistance - what\u2019s dosing got to do with it? Crit. Care Med. \n                           36, 2433\u20132440 (2008).","journal-title":"Crit. Care Med."},{"key":"3338_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/CCM.0000000000000029","volume":"42","author":"AA Udy","year":"2014","unstructured":"Udy, A. A. et al. Augmented Renal Clearance in the ICU. Crit. Care Med. \n                           42, 520\u2013527 (2014).","journal-title":"Crit. Care Med."},{"key":"3338_CR9","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1186\/cc9091","volume":"14","author":"FS Taccone","year":"2010","unstructured":"Taccone, F. S. et al. Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock. Crit. Care \n                           14, R126 (2010).","journal-title":"Crit. Care"},{"key":"3338_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ACO.0000000000000302","volume":"29","author":"FS Taccone","year":"2016","unstructured":"Taccone, F. S., Bond, O., Cavicchi, F. Z. & Hites, M. Individualized antibiotic strategies. Curr. Opin. Anaesthesiol. \n                           29, 1 (2016).","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"3338_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0925-4005(90)80209-I","volume":"1","author":"A Manz","year":"1990","unstructured":"Manz, A., Widmers, H. M. & Graber, N. Miniaturized total chemical analysis systems: A novel concept for chemical sensing. Sensors Actuators B Chem. \n                           1, 244\u2013248 (1990).","journal-title":"Sensors Actuators B Chem."},{"key":"3338_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00216-010-3678-8","volume":"397","author":"AHC Ng","year":"2010","unstructured":"Ng, A. H. C., Uddayasankar, U. & Wheeler, A. R. Immunoassays in microfluidic systems. Anal. Bioanal. Chem. \n                           397, 991\u20131007 (2010).","journal-title":"Anal. Bioanal. Chem."},{"key":"3338_CR13","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.bios.2005.11.017","volume":"21","author":"S Kwakye","year":"2006","unstructured":"Kwakye, S., Goral, V. N. & Baeumner, A. J. Electrochemical microfluidic biosensor for nucleic acid detection with integrated minipotentiostat. Biosens. Bioelectron. \n                           21, 2217\u20132223 (2006).","journal-title":"Biosens. Bioelectron."},{"key":"3338_CR14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.bios.2006.06.024","volume":"22","author":"AL Ghindilis","year":"2007","unstructured":"Ghindilis, A. L. et al. CombiMatrix oligonucleotide arrays: Genotyping and gene expression assays employing electrochemical detection. Biosens. Bioelectron. \n                           22, 1853\u20131860 (2007).","journal-title":"Biosens. Bioelectron."},{"key":"3338_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/elan.201400015","volume":"26","author":"M D\u00edaz-Gonz\u00e1lez","year":"2014","unstructured":"D\u00edaz-Gonz\u00e1lez, M., Mu\u00f1oz-Berbel, X., Jim\u00e9nez-Jorquera, C., Baldi, A. & Fern\u00e1ndez-S\u00e1nchez, C. Diagnostics Using Multiplexed Electrochemical Readout Devices. Electroanalysis \n                           26, 1154\u20131170 (2014).","journal-title":"Electroanalysis"},{"key":"3338_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/bit.20224","volume":"89","author":"CC Weber","year":"2005","unstructured":"Weber, C. C. et al. Broad-spectrum protein biosensors for class-specific detection of antibiotics. Biotechnol. Bioeng. \n                           89, 9\u201317 (2005).","journal-title":"Biotechnol. Bioeng."},{"key":"3338_CR17","first-page":"393","volume":"61","author":"MT Gallegos","year":"1997","unstructured":"Gallegos, M. T., Schleif, R., Bairoch, A., Hofmann, K. & Ramos, J. L. Arac\/XylS family of transcriptional regulators. Microbiol Mol Biol Rev \n                           61, 393\u2013410 (1997).","journal-title":"Microbiol Mol Biol Rev"},{"key":"3338_CR18","doi-asserted-by":"crossref","unstructured":"Kling, A. et al. Multianalyte Antibiotic Detection on an Electrochemical Microfluidic Platform. Anal. Chem. 88, 10036\u201310043 (2016).","DOI":"10.1021\/acs.analchem.6b02294"},{"key":"3338_CR19","doi-asserted-by":"crossref","unstructured":"Dincer, C., Bruch, R., Kling, A., Dittrich, P. S. & Urban, G. A. Multiplexed point-of-care testing - xPOCT. Trends Biotechnol. 35, (2017).","DOI":"10.1016\/j.tibtech.2017.03.013"},{"key":"3338_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","volume":"32","author":"A Zapun","year":"2008","unstructured":"Zapun, A., Contreras-Martel, C. & Vernet, T. Penicillin-binding proteins and \u03b2-lactam resistance. FEMS Microbiol. Rev. \n                           32, 361\u2013385 (2008).","journal-title":"FEMS Microbiol. Rev."},{"key":"3338_CR21","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1128\/AAC.05142-14","volume":"59","author":"O Kocaoglu","year":"2015","unstructured":"Kocaoglu, O., Tsui, H. C. T., Winkler, M. E. & Carlson, E. E. Profiling of \u03b2-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39. Antimicrob. Agents Chemother. \n                           59, 3548\u20133555 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3338_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ab.2013.07.042","volume":"442","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Wang, Z., Wen, K., Liang, X. & Shen, J. Penicillin-binding protein 3 of Streptococcus pneumoniae and its application in screening of \u03b2-lactams in milk. Anal. Biochem. \n                           442, 158\u2013165 (2013).","journal-title":"Anal. Biochem."},{"key":"3338_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bios.2014.02.058","volume":"58","author":"J Horak","year":"2014","unstructured":"Horak, J., Dincer, C., Bakirci, H. & Urban, G. Sensitive, rapid and quantitative detection of substance P in serum samples using an integrated microfluidic immunochip. Biosens. Bioelectron. 58, 186\u2013192 (2014).","journal-title":"Biosens. Bioelectron"},{"key":"3338_CR24","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1039\/C5LC00796H","volume":"15","author":"L Armbrecht","year":"2015","unstructured":"Armbrecht, L. et al. Self-assembled magnetic bead chains for sensitivity enhancement of microfluidic electrochemical biosensor platforms. Lab Chip \n                           15, 4314\u20134321 (2015).","journal-title":"Lab Chip"},{"key":"3338_CR25","unstructured":"Moser, I., Jobst, G. & Gamp, T. Verfahren zur Herstellung eines \u2018lab on chip\u2019 aus Photoresistmaterial f\u00fcr medizinisch diagnostische Anwendungen. (2001)."},{"key":"3338_CR26","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1039\/C6AN01330A","volume":"141","author":"C Dincer","year":"2016","unstructured":"Dincer, C. et al. Designed miniaturization of microfluidic biosensor platforms using the stop-flow technique. Analyst \n                           141, 6073\u20136079 (2016).","journal-title":"Analyst"},{"key":"3338_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","volume":"24","author":"JS Kang","year":"2009","unstructured":"Kang, J. S. & Lee, M. H. Overview of therapeutic drug monitoring. Korean J. Intern. Med. \n                           24, 1\u201310 (2009).","journal-title":"Korean J. Intern. Med."},{"key":"3338_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1128\/AAC.9.5.741","volume":"9","author":"RD Foord","year":"1976","unstructured":"Foord, R. D. Cefuroxime: human pharmacokinetics. Antimicrob. Agents Chemother. \n                           9, 741\u2013747 (1976).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3338_CR29","first-page":"443","volume":"19","author":"A Chemother","year":"1981","unstructured":"Chemother, A. Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrob. Agents Chemother.\u00a019, 443\u2013449 (1981).","journal-title":"Pharmacokinetics of Cefuroxime in Normal and Impaired Renal Function: Comparison of High-Pressure Liquid."},{"key":"3338_CR30","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","volume":"64","author":"NA Kratochwil","year":"2002","unstructured":"Kratochwil, N. A., Huber, W., M\u00fcller, F., Kansy, M. & Gerber, P. R. Predicting plasma protein binding of drugs: A new approach. Biochem. Pharmacol. \n                           64, 1355\u20131374 (2002).","journal-title":"Biochem. Pharmacol."},{"key":"3338_CR31","first-page":"236","volume":"9","author":"M Nishida","year":"1969","unstructured":"Nishida, M. et al. In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob. Agents Chemother. \n                           9, 236\u2013243 (1969).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3338_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archinte.1974.00320150081009","volume":"133","author":"C Regamey","year":"1974","unstructured":"Regamey, C., Gordon, R. & Kirby, W. Cefazolin vs cephalothin and cephaloridine: A comparison of their clinical pharmacology. Arch. Intern. Med. \n                           133, 407\u2013410 (1974).","journal-title":"Arch. Intern. Med."},{"key":"3338_CR33","unstructured":"Antibiotic Expert Group. Therapeutic Guidelines \u2013 Antibiotic (Version 14). (2010)."},{"key":"3338_CR34","doi-asserted-by":"publisher","first-page":"8539","DOI":"10.1007\/s00216-016-9979-9","volume":"408","author":"J Kang","year":"2016","unstructured":"Kang, J. et al. Rapid determination of \u03b2-lactam antimicrobial resistance in bacteria by a liquid chromatography-mass spectrometry-based method. Anal. Bioanal. Chem. \n                           408, 8539\u20138549 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"3338_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/bmc.2947","volume":"27","author":"S Fortuna","year":"2013","unstructured":"Fortuna, S., De Pascale, G., Ragazzoni, E., Antonelli, M. & Navarra, P. Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage. Biomed. Chromatogr. \n                           27, 1489\u20131496 (2013).","journal-title":"Biomed. Chromatogr."},{"key":"3338_CR36","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.trac.2010.06.004","volume":"29","author":"C Ch\u00e1fer-Peric\u00e1s","year":"2010","unstructured":"Ch\u00e1fer-Peric\u00e1s, C., Maquieira, \u00c1. & Puchades, R. Fast screening methods to detect antibiotic residues in food samples. TrAC - Trends Anal. Chem. \n                           29, 1038\u20131049 (2010).","journal-title":"TrAC - Trends Anal. Chem."},{"key":"3338_CR37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1039\/b817836d","volume":"134","author":"K Kloth","year":"2009","unstructured":"Kloth, K. et al. A regenerable immunochip for the rapid determination of 13 different antibiotics in raw milk. Analyst \n                           134, 1433 (2009).","journal-title":"Analyst"},{"key":"3338_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/518027a","volume":"518","author":"A Bradbury","year":"2015","unstructured":"Bradbury, A. & Pluckthun, A. Reproducibility: Standardize antibodies used in research. Nature \n                           518, 27\u201329 (2015).","journal-title":"Nature"},{"key":"3338_CR39","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1039\/a805166f","volume":"123","author":"R Dietrich","year":"1998","unstructured":"Dietrich, R., Usleber, E. & M\u00e4rtlbauer, E. The potential of monoclonal antibodies against ampicillin for the preparation of a multi-immunoaffinity chromatography for penicillins. Analyst \n                           123, 2749\u201354 (1998).","journal-title":"Analyst"},{"key":"3338_CR40","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00216-012-5960-4","volume":"403","author":"R Babington","year":"2012","unstructured":"Babington, R., Matas, S., Marco, M. P. & Galve, R. Current bioanalytical methods for detection of penicillins. Anal. Bioanal. Chem. \n                           403, 1549\u20131556 (2012).","journal-title":"Anal. Bioanal. Chem."},{"key":"3338_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","volume":"73","author":"JA Roberts","year":"2012","unstructured":"Roberts, J. A., Norris, R., Paterson, D. L. & Martin, J. H. Therapeutic drug monitoring of antimicrobials. Br. J. Clin. Pharmacol. \n                           73, 27\u201336 (2012).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"3338_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","volume":"36","author":"JA Roberts","year":"2010","unstructured":"Roberts, J. A. et al. Therapeutic drug monitoring of \u00df-lactams in critically ill patients: Proof of concept. Int. J. Antimicrob. Agents \n                           36, 332\u2013339 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"3338_CR43","doi-asserted-by":"crossref","unstructured":"Viberg, A., Cars, O., Karlsson, M. O. & J\u00f6nsson, S. Estimation of cefuroxime dosage using pharmacodynamic targets, MIC distributions, and minimization of a risk function. J. Clin. Pharmacol. 48, 1270\u201381 (2008).","DOI":"10.1177\/0091270008320923"},{"key":"3338_CR44","doi-asserted-by":"crossref","unstructured":"Craig, W. & Andes, D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. The Pediatric infectious disease journal \n                           15, (Williams & Wilkins, 1987).","DOI":"10.1097\/00006454-199610000-00032"},{"key":"3338_CR45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/AAC.7.5.606","volume":"7","author":"ES Rattie","year":"1975","unstructured":"Rattie, E. S. & Ravin, L. J. Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans. Antimicrob. Agents Chemother. \n                           7, 606\u201313 (1975).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3338_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2165\/00003088-199120060-00004","volume":"20","author":"PR Gwilt","year":"1991","unstructured":"Gwilt, P. R., Nahhas, R. R. & Tracewell, W. G. The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans. Clin. Pharmacokinet. \n                           20, 477\u2013490 (1991).","journal-title":"Clin. Pharmacokinet."},{"key":"3338_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00609865","volume":"12","author":"PE Gower","year":"1977","unstructured":"Gower, P. E. & Dash, C. H. The pharmacokinetics of cefuroxime after intravenous injection. Eur. J. Clin. Pharmacol. \n                           12, 221\u2013227 (1977).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"3338_CR48","unstructured":"Viberg, A. Using Pharmacokinetic and Pharmacodynamic Principles to Evaluate Individualisation of Antibiotic Dosing \u2013 Emphasis on Cefuroxime. (2006)."},{"key":"3338_CR49","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00228-011-1048-x","volume":"67","author":"S Van Kralingen","year":"2011","unstructured":"Van Kralingen, S. et al. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients. Eur. J. Clin. Pharmacol. \n                           67, 985\u2013992 (2011).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"3338_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/BF01970173","volume":"14","author":"MJ Koot","year":"1992","unstructured":"Koot, M. J. et al. High pressure liquid chromatographic analysis of the serum concentration of cefuroxime after an intravenous bolus injection of cefuroxime in patients with a coronary artery bypass grafting. Pharm. Weekbl. Sci. Ed. \n                           14, 360\u2013364 (1992).","journal-title":"Pharm. Weekbl. Sci. Ed."},{"key":"3338_CR51","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1128\/AAC.05033-11","volume":"55","author":"A Douglas","year":"2011","unstructured":"Douglas, A. et al. Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery. Antimicrob. Agents Chemother. \n                           55, 5238\u20135242 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3338_CR52","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1128\/AAC.01348-13","volume":"57","author":"AA Bhalodi","year":"2013","unstructured":"Bhalodi, A. A., Housman, S. T., Shepard, A., Nugent, J. & Nicolau, D. P. Tissue pharmacokinetics of cefazolin in patients with lower limb infections. Antimicrob. Agents Chemother. \n                           57, 5679\u20135683 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3338_CR53","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","volume":"31","author":"J Garnacho-Montero","year":"2003","unstructured":"Garnacho-Montero, J. et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit. Care Med. \n                           31, 2742\u20132751 (2003).","journal-title":"Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03338-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:11:14Z","timestamp":1671772274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3338"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03338-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]},"assertion":[{"value":"1 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3127"}}